Mega menu

Home
Product regulation
Product regulation

Understand your obligations and access industry Guidance and other information about the products we regulate.
Safety and shortages
Safety and shortages

Access information about product recalls, shortages and other alerts, and learn how we manage safety.
Resources and guidance
Resources and guidance

Get information to help you understand our work, regulations and industry obligations.
Business services
Business services

Access our systems to submit applications, manage forms, make payments and communicate securely.

Roche Products Pty Ltd

Regulatory activities for this sponsor.

- LinkedIn
- (Twitter)
- Facebook
- Email

Loading...

Type

ARTG (82)
Cancellation by sponsor (49)
Australian public assessment report (AusPar) (43)
Prescription medicine registration (32)
Prescription medicine decision summary (5)
Designation or determination (1)
Prescription medicine evaluation (1)

Date

2025 (15)
2024 (15)
2023 (22)
2022 (9)
2021 (20)
2020 (16)
2019 (13)
2018 (11)
2017 (16)
2016 (6)
2015 (8)
2014 (5)
2013 (11)
2012 (3)
2011 (5)
2010 (4)
2009 (12)
2008 (2)
2006 (6)
2002 (1)
2000 (3)
1999 (1)
1997 (2)
1994 (1)
1993 (1)
1991 (5)

Search

Sponsor content

213 result(s) found, displaying 111 to 120

BACTRIM SUGAR-FREE oral liquid bottle Cancelled under Section 30(1)(c) of the Act

2 October 2019

Cancellation by sponsor

Requested by Roche Products Pty Ltd
KADCYLA (Roche Products Pty Ltd)

26 September 2019

Prescription medicine registration

Active ingredients: trastuzumab emtansine (rch).
TECENTRIQ (Roche Products Pty Ltd)

17 July 2019

Prescription medicine registration

Active ingredients: atezolizumab (rch).
BACTRIM SUGAR-FREE oral liquid bottle Cancelled under Section 30(1)(c) of the Act

7 May 2019

Cancellation by sponsor

Requested by Roche Products Pty Ltd
TECENTRIQ (Roche Products Pty Ltd)

12 April 2019

Prescription medicine registration

Active ingredients: atezolizumab.
TECENTRIQ (Roche Products Pty Ltd)

12 April 2019

Prescription medicine registration

Active ingredients: atezolizumab.
XELODA Capecitabine 500mg tablet blister pack Cancelled under Section 30(1)(c) of the Act

2 April 2019

Cancellation by sponsor

Requested by Roche Products Pty Ltd
ACTEMRA (Roche Products Pty Ltd)

22 March 2019

Prescription medicine registration

Active ingredients: tocilizumab.
COPEGUS ribavirin 200mg film coated tablet bottle Cancelled under Section 30(1)(c) of the Act

5 March 2019

Cancellation by sponsor

Requested by Roche Products Pty Ltd
COTELLIC cobimetinib 20 mg film-coated tablet blister pack (237017)

6 April 2016

ARTG

Australian Register of Therapeutic Goods (ARTG) information for COTELLIC cobimetinib 20 mg film-coated tablet blister pack.

Pages

First page
Previous page
…
Page 8
Page 9
Page 10
Page 11
Current page 12
Page 13
Page 14
Page 15
Page 16
…
Next page
Last page

Is there anything wrong with this page?

Help us improve

Using our website

Accessibility
Privacy
Security
Disclaimer
Copyright
Freedom of information
Acronyms and glossary terms

Quick links

Search our databases
Report a problem or side effect
TGA Business Services
Special Access Scheme
Authorised Prescriber
Office of Drug Control
State and territory contacts

Connect with us

Email subscriptions
Contact us
Facebook
(formerly Twitter)
Youtube
Instagram
LinkedIn

Help us improve

We are always looking for ways to improve our website.

Provide feedback

The Department of Health, Disability and Ageing acknowledges First Nations peoples as the Traditional Owners of Country throughout Australia, and their continuing connection to land, sea and community. We pay our respects to them and their cultures, and to all Elders both past and present.